LAB token plunged more than 36% in 24 hours due to scheduled investor unlocks, insider transfers, and exchange activity increasing selling pressure. These events erased about 99% of LAB's value from its all-time high, raising concerns about the project's transparency and legitimacy. Despite heavy selling, LAB still holds significant market liquidity and remains listed on major exchanges. The token's future depends on renewed buying demand and stronger liquidity to stabilize its price amid ongoing speculative trading and capital outflows.
Halper Sadeh LLC is investigating whether shareholders of NextEra Energy (NEE), Corebridge Financial (CRBG), RE/MAX Holdings (RMAX), and Apogee Therapeutics (APGE) are receiving fair deals in their companies' proposed mergers or sales. The firm highl...
Halper Sadeh LLC is investigating the merger between NextCure, Inc. and Avere Therapeutics, Inc. to determine if NextCure's shareholders are receiving a fair price. The firm questions whether NextCure's board fulfilled their duties by securing the be...
AppFolio, Inc. saw its stock price increase by 2.46% to $179.90, outperforming major indices, driven by strong momentum and AI-focused growth strategies. Insider DUCA MAURICE J sold 3,500 shares worth $630,525 but still holds over 88,000 shares. Anal...
ASML Holding N.V., Europe's largest semiconductor equipment supplier, is set to report Q2 earnings on July 15, 2026, with analysts forecasting an EPS of $7.92 and revenue of $10.25 billion, reflecting a 15% year-over-year EPS increase. The company pl...
Erasca Inc., a precision oncology firm, saw its stock jump 8.94% to $19.50 after positive preliminary data showed a 57% response rate for its pancreatic cancer drug candidate ERAS-0015. Jefferies raised its price target to $24, implying a 23% upside....
